Drug-induced delayed hypersensitivity syndrome

Revista Clinica Espanola

Volumn 202, Issue 6, 2002, Pages 339-346

  Perez Pimiento A J ^a   Calvo Manuel, E ^a   Lozano Tonkin C ^a   Espinos Perez D ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; AZATHIOPRINE; CARBAMAZEPINE; DAPSONE; DILTIAZEM; DOXYCYCLINE; GABAPENTIN; INTERLEUKIN 5; ISONIAZID; LAMOTRIGINE; METHYLDOPA; MEXILETINE; MIDECAMYCIN; MINOCYCLINE; OXIPURINOL; PHENOBARBITAL; PHENYLBUTAZONE; PHENYTOIN; SALAZOSULFAPYRIDINE; SORBINIL; SULFAMETHOXAZOLE; SULFONAMIDE; TERBINAFINE; TIAGABINE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZALCITABINE; ZIMELDINE; ANTIGOUT AGENT;

ACUTE HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; EOSINOPHILIA; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE RESPONSE; KIDNEY FAILURE; LIVER MICROSOME; RASH; REVIEW; TIME;

ALLOPURINOL; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; GOUT SUPPRESSANTS; HUMANS; SULFONAMIDES; TIME FACTORS;

EID: 0035983594     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0014-2565(02)71071-0     Document Type: Review

References (86)

1. Anticonvulsant hypersensitivity syndrome: Incidence, prevention and management
2. Antiepileptic drug hypersensitivity syndrome
3. Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamacepine
4. Phenytoin hypersensitivity hepatitis and mononucleosis syndrome
5. Mononucleosis-like illness as a manifestation of carbamazepine-induced anticonvulsant hypersensitivity syndrome
6. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with sosinophilia and systemic symptoms: DRESS)
7. DIDMOHS: A proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome
8. Phenytoin hypersensitivity: 38 cases
9. Drug hypersensitivity syndrome
10. Drug induced pseudolymphoma and hypersensitivity syndrome: Two different clinical entities
11. Generalized nodular cutaneous pseudolimphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin
12. Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk
13. Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital
14. Antiepileptic drug hypersensitivity syndrome: In vitro and clinical observations
15. Fatal benign phenytoin lymphadenopathy
16. The phenytoin syndrome
17. Phenytoin hypersensitivity syndrome: A case report
18. Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome
19. The anticonvulsant hypersensitivity syndrome
20. Síndrome de hipersensibilidad a fenitoína
21. Systemic corticosteroids in the phenytoin hypersensitivity syndrome
22. Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome
23. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine
24. Phenytoin hypersensitivity syndrome with positive patch test. A possible cross-reactivity with amitriptiline
25. Phenytoin hypersensitivity syndrome with fatal evolution
26. Successful treatment with gabapentin in the presence of hypersensitivity syndrome to phenytoin and carbamazepine: A report of three cases
27. Anticonvulsant hypersensitivity syndrome occurring as sepsis with multiorgan dysfunction
28. Síndrome de hipersensibilidad por anticonvulsivantes
29. Carbamazepine-induced anticonvulsant hypersensitivity syndrome: Pathogenic and diagnostic considerations
30. Carbamazepine hypersensitivity syndrome: Report of 4 cases and review of the literature
31. Colitis may be part of the antiepileptic drug hypersensitivity syndrome
32. Anticonvulsant hypersensitivity syndrome due to carbamazepine
33. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome
34. A case of tubulointerstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity
35. Síndrome de hipersensibilidad secundario a fenobarbital
36. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome
37. Phenytoin-like hypersensitivity associated with lamotrigine
38. Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant-induced hypersensitivity syndrome
39. Lamotrigine-associated anticonvulsant hypersensitivity syndrome
40. Lamotrigine and phenobarbitone-associated hypersensitivity syndrome: Resolution without corticosteroids
41. Hypersensitivity reaction in a child due to lamotrigine
42. Lamotrigine overdose presenting as anticonvulsant hypersensitivity syndrome
43. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro
44. Hypersensitivity syndrome due to 2 anticonvulsant drugs
45. Severe hypersensitivity reactions associated with allopurinol
46. The allopurinol hypersensitivity syndrome
47. The allopurinol hypersensitivity syndrome: Unnecessary morbidity and mortality
48. Síndrome de hipersensibilidad por alopurinol: A propósito de dos casos y revisión de la literatura
49. Cell-mediated immunity in allopurinol-induced hypersensitivity
50. Síndrome de hipersensibilidad por alopurinol. Un caso de necrosis hepática masiva
51. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome
52. Allopurinol hypersensitivity syndrome: Hypersensitivity to oxypurinol but not allopurinol
53. Allopurinol hypersensitivity syndrome: A review
54. Dapsone hypersensitivity: The sulfone syndrome revisited
55. Liver involvement in the sulphone syndrome
56. Dapsone hypersensitivity syndrome
57. The dapsone hypersensitivity syndrome occurring in a patient with dermatitis herpetiformis
58. Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus
59. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro «rechallenge» with hydroxilamine metabolites
60. Differences in metabolism of sulfonamides predisposing to idiosincratic toxicity
61. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins
62. Trimethoprim/sulfamethoxazole-induced hypersensitivity syndrome
63. Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction
64. Hypersensitivity reaction to sulfasalazine with severe hepatoxicity
65. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6
66. Acute hepatitis and exfoliative dermatitis associated with minocycline
67. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction
68. Serious adverse reactions induced by minocicline. Report of 13 patients and review of the literature
69. Comparative safety of tetracycline, minocycline, and doxycicline
70. Jaundice and exfoliative dermatitis due to phenylbutazone
71. In vitro assessment of a hypersensitivity syndrome associated with sorbinil
72. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine
73. Methyldopa hypersensitivity syndrome
74. Rhabdomyolisis associated with azathioprine hypersensitivity syndrome
75. Hypersensitivity syndrome associated with zalcitabine therapy
76. Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocitosis and liver disfunction
77. Acute hepatitis during hypersensitivity syndrome due to midecamycin
78. Hypersensitivity syndrome reaction to oral terbinafine
79. The spectrum of cutaneous reactions associated with diltiazem: Three cases and review of the literature
80. Hypersensitivity syndrome from isoniazid
81. Activation of drug-specific CD4+ and CD8+ cells in individuals allergic to sulfonamides, phenytoin and carbamazepine
82. Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response
83. Erythema multiforme to phenobarbital: Involvement of eosinophils and T cells expressing the skin homing receptor
84. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome
85. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity syndrome
86. Mechanisms of drug reactions: The metabolic track